A phase 2 study of ofatumumab in combination with hyper-CVAD/MA in patients with newly diagnosed mantle cell lymphoma

Category Primary study
JournalHemaSphere
Year 2019
This article has no abstract
Epistemonikos ID: e82aa13ef913ccd1978c216e1af9f1d0d90d68bd
First added on: Feb 11, 2025